Views & analysis - Pharmaphorum

Trending

Latest Views & analysis

in Views & Analysis
The constants of pharma marketing
January 8, 2019 Share
X
The constants of pharma marketing
https://pharmaphorum.com/views-analysis-sales-marketing/the-constants-of-pharma-marketing/
in DMD Main
Curing DMD: Travelling together to find a meaningful destination
January 23, 2019 Share
X
Curing DMD: Travelling together to find a meaningful destination
https://pharmaphorum.com/disease-spotlight/dmd-main/curing-dmd-travelling-together-to-find-a-meaningful-destination/
in Views & Analysis
Rethinking adherence programmes
January 22, 2019 Share
X
Rethinking adherence programmes
https://pharmaphorum.com/views-analysis-digital/rethinking-adherence-programmes/
in Views & Analysis
JP Morgan Healthcare: where science, tech and finance collide
January 21, 2019 Share
X
JP Morgan Healthcare: where science, tech and finance collide
https://pharmaphorum.com/views-analysis-sales-marketing/jp-morgan-healthcare-science-tech-finance-collide/
in R&D
Opening doors in pharmaceutical development
January 21, 2019 Share
X
Opening doors in pharmaceutical development
https://deep-dive.pharmaphorum.com/magazine/disruptive-technologies/machine-learning-opening-doors-in-pharmaceutical-development/

JP Morgan Healthcare: where science, tech and finance collide

JP Morgan Healthcare: where science, tech and finance collide

Welcome to 2019! Hopefully by now you’re managing to ease yourself back into things, no doubt with good

X

JP Morgan Healthcare: where science, tech and finance collide

https://pharmaphorum.com/views-analysis-sales-marketing/jp-morgan-healthcare-science-tech-finance-collide/

Opening doors in pharmaceutical development

Opening doors in pharmaceutical development

Evidera surveys the adoption of machine learning by the pharmaceutical industry and looks at how it can increase

X

Opening doors in pharmaceutical development

https://deep-dive.pharmaphorum.com/magazine/disruptive-technologies/machine-learning-opening-doors-in-pharmaceutical-development/

Digital health round-up: J&J joins with Apple and more AI deals

Digital health round-up: J&J joins with Apple and more AI deals

Richard Staines presents a round-up of the recent major developments in the field of digital health

X

Digital health round-up: J&J joins with Apple and more AI deals

https://pharmaphorum.com/views-analysis-digital/digital-health-jj-joins-with-apple-more-ai-deals/

Recommended authors

More Views & Analysis

Expanding the definition of medicine

Expanding the definition of medicine

Digital therapeutics are adding new elements to the medical world, but their place in the pharmaceutical sector is

X

Expanding the definition of medicine

https://deep-dive.pharmaphorum.com/magazine/disruptive-technologies/digital-therapeutics-expanding-the-definition-of-medicine/

Brexit and beyond: the challenges ahead for pharma

Brexit and beyond: the challenges ahead for pharma

Brexit, and the political fallout from approving any deal, will continue to dominate British politics in 2019. It

X

Brexit and beyond: the challenges ahead for pharma

https://pharmaphorum.com/views-analysis-sales-marketing/brexit-challenges-ahead-pharma/

Women in Science: AstraZeneca

Women in Science: AstraZeneca

We speak to three of AstraZeneca’s senior leaders about their careers, the future of their therapy areas and

X

Women in Science: AstraZeneca

https://pharmaphorum.com/r-d/views-analysis-r-d/women-in-science-astrazeneca/

Young advocate’s patient voice heard at top levels of power

Young advocate’s patient voice heard at top levels of power

Listening to the patient voice gives industry the opportunity to learn about the challenges people with long-term conditions

X

Young advocate’s patient voice heard at top levels of power

https://pharmaphorum.com/views-analysis-patients/young-advocates-patient-voice/

Adding value to generics and biosimilars

Adding value to generics and biosimilars

Paul Tredwell, vice president for specialty brands at Accord Healthcare says innovation is vital for success in today’s

X

Adding value to generics and biosimilars

https://pharmaphorum.com/r-d/views-analysis-r-d/adding-value-to-generics-and-biosimilars/

The age of digital medicine is here

The age of digital medicine is here

As technology and traditional healthcare converge, some trends in cutting-edge digital health innovation are emerging. Andrew Thompson, CEO

X

The age of digital medicine is here

https://deep-dive.pharmaphorum.com/magazine/disruptive-technologies/the-age-of-digital-medicine-is-here/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com